My watch list
my.bionity.com  
Login  

499 Current news from france

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

Alnylam and Sanofi enter into strategic restructuring

Optimizing development and commercialization of RNAi therapeutics for rare diseases

09-Jan-2018

Alnylam Pharmaceuticals, Inc. and Sanofi announced a strategic restructuring of their RNAi therapeutics alliance to streamline and optimize development and commercialization of certain products for the treatment of rare genetic diseases. Specifically, Alnylam will obtain global development and ...

more

Discngine raises €1.1 million in Series A funding round

12-Dec-2017

Discngine, a software company specializing in applications for life sciences research, today announces a Series A financing round of €1.1 million ($1.3M), received from Extens Développement e-Santé. The funds raised will allow Discngine to move forward with its Software-as-a-Service (SaaS) ...

more

First bio-isobutene batch delivered to L'Oréal by Global Bioenergies

29-Nov-2017

Global Bioenergies announced delivery of a first batch of sustainable cosmetic ingredients to L'Oréal. It was produced as part of the ISOPROD project, supported by the French State's Investissements for the Future Program. Using proven technologies, Global Bioenergies condensed isobutene ...

more

image description
3-D axon assemblies pave the way for drug discovery

30-Oct-2017

Axons are the structures through which neurons transmit information to other cells. In the body, they aggregate to form fascicles. Several technologies allow scientists to generate and study single axons in the lab, but none are effective at creating nerve fascicles. A collaboration between ...

more

VEXIM to be acquired by Stryker Corporation

26-Oct-2017

Stryker Corporation acquired a majority of the share capital and voting rights ofVEXIM,a medical device company specializing in the minimally invasive treatment of vertebral fractures. Stryker Corporation has indirectly acquired 4,115,151 VEXIM shares, representing 50.7% of the share capital ...

more

Sanofi invests in new vaccine production facility in France

13-Oct-2017

Sanofi is investing €170 million to expand a vaccine manufacturing site in Val de Reuil, France. The expansion further strengthens Sanofi's position as one of the world's leading seasonal flu vaccine providers. The new facility will allow Sanofi Pasteur, the Vaccines global business unit of ...

more

Evonik opens site in France’s Cosmetic Valley

11-Oct-2017

At the end of September, Evonik celebrated the opening of the new site for its Evonik Advanced Botanicals subsidiary in Tours (France). Now part of the Personal Care Business Line, the new subsidiary was created in 2016 when Evonik acquired experts in biotechnological production of plant-based ...

more

Enterome to move its research laboratories

Establishing labs in France's biocluster Genopole

21-Sep-2017

Enterome, a pioneer of innovative therapies for microbiome-related diseases announced that the Company is moving its research laboratories to Genopole, a leading biocluster dedicated to biotechnology and research in genomics and genetics. The new laboratories brings Enterome closer to its ...

more

image description
When enzymes rival platinum

05-Sep-2017

A fuel cell converts chemical energy into electrical energy via hydrogen combustion. Though it is considered to be a clean technology - because it does not emit greenhouse gases - fuel cells do use costly rare metal catalysts1, such as platinum, to oxidize hydrogen and reduce oxygen. In recent ...

more

Sanofi completes the acquisition of Protein Sciences

30-Aug-2017

Sanofi announced that it has completed the acquisition of Protein Sciences, a vaccines biotechnology company based in Meriden, Connecticut in the United States. This completion follows Federal Trade Commission approval, having met all the conditions required for the closing of the transaction. ...

more

Page 3 From 50
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE